Anchorage, AK 的 卵巢癌 臨床試驗
7 項針對 卵巢癌 的研究正在 Anchorage（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Alaska Women's Cancer Care, Anchorage
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中3 期
- Alaska Womens Cancer Care Akwcc, Anchorage
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
招募中3 期
- Alaska Women's Cancer Care ( Site 0096), Anchorage
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
招募中
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- 還有 3 項
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- 還有 3 項
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
招募中2/3 期
- Alaska Women's Cancer Care, Anchorage
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Alaska Oncology and Hematology, Anchorage
其他城市的 卵巢癌 試驗
- Houston, TX89 項研究
- New York City, NY69 項研究
- Boston, MA61 項研究
- Los Angeles, CA50 項研究
- Nashville, TN49 項研究
- Arlington, VA46 項研究
- Philadelphia, PA44 項研究
- Columbus, OH39 項研究
- St. Louis, MO38 項研究
- Chicago, IL36 項研究
- San Antonio, TX31 項研究
- Cleveland, OH30 項研究
Anchorage 的其他研究
- 非小細胞肺癌8 項研究
- 乳癌7 項研究
- 肺癌6 項研究
- 前列腺癌4 項研究
- 胰臟癌4 項研究
- 子宮內膜癌4 項研究
- 胃癌3 項研究
- 食道癌3 項研究
- 癌症（所有類型）3 項研究
- 急性雙表型白血病3 項研究
- 大腸直腸癌3 項研究
- 黑色素瘤3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。